(Q42261776)

English

Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection

scientific article published on 19 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Circulating chemokine (C-X-C Motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection (English)

1 reference

Europe PubMed Central

19 October 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

author name string

Yongyin Li

1

1 reference

Europe PubMed Central

19 October 2017

Shiwu Ma

2

1 reference

Europe PubMed Central

19 October 2017

Libo Tang

3

1 reference

Europe PubMed Central

19 October 2017

Yun Li

4

1 reference

Europe PubMed Central

19 October 2017

Wei Wang

5

1 reference

Europe PubMed Central

19 October 2017

Xuan Huang

6

1 reference

Europe PubMed Central

19 October 2017

Qintao Lai

7

1 reference

Europe PubMed Central

19 October 2017

Mingxia Zhang

8

1 reference

Europe PubMed Central

19 October 2017

Jian Sun

9

1 reference

Europe PubMed Central

19 October 2017

Chris Kafai Li

10

1 reference

Europe PubMed Central

19 October 2017

William G H Abbott

11

1 reference

Europe PubMed Central

19 October 2017

Nikolai V Naoumov

12

1 reference

Europe PubMed Central

19 October 2017

Yu Zhang

13

1 reference

Europe PubMed Central

19 October 2017

Jinlin Hou

14

1 reference

Europe PubMed Central

19 October 2017

language of work or name

0 references

publication date

19 August 2013

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

58

1 reference

Europe PubMed Central

19 October 2017

4

1 reference

Europe PubMed Central

19 October 2017

1277-1286

1 reference

Europe PubMed Central

19 October 2017

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Antigen-specific memory B cell development

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Follicular helper CD4 T cells (TFH)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Signals that influence T follicular helper cell differentiation and function.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Direct ex vivo evaluation of long-lived protective antiviral memory B cell responses against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

B-cell responses during primary and secondary dengue virus infections in humans

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

IL-21: an executor of B cell fate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Immune tolerance split between hepatitis B virus precore and core proteins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

21 January 2018

Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

7 January 2021

based on heuristic

inferred from DOI database lookup

High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26489

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26489

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42261776&oldid=1940393137"